Molecule Holdings Inc., a Canadian craft-focused cannabis beverage production company, is pleased to announce that it has signed a cannabis supply agreement with ABcann Medicinals Inc., a wholly owned subsidiary of Vivo Cannabis Inc., enabling Molecule to use Vertosa emulsions for use in its cannabis beverages. ABcann has territory rights to Vertosa emulsion technology and generates the products on site. Vertosa’s customized water-compatible solutions are reported to accelerate onset time, prolong shelf-life, increase bioavailability, and improve the taste profile of cannabis-infused products.
“We are excited to be working with Vertosa’s emulsion tech and are impressed with their rigor and the test results we have seen. We are happy to be using this technology to infuse beverages and pleased to be working on this with Vivo,” said Molecule CEO Phil Waddington. “We are very pleased about the signing of this agreement with Molecule. We look forward to a long and mutually beneficial relationship with Molecule,” said Michael Bumby, CFO of VIVO.
Molecule works with client-partners to engage in the production of cannabis-infused beverages and edibles. For more information visit: www.molecule.ca
Vertosa creates industry-leading active ingredients for infused product makers. Their patent pending nano- and micro-emulsions are carefully designed for the specific needs of each customer, with pre-suspended aqueous solutions that create homogeneous and stable products while maximizing bioavailability, clarity, and taste. Learn more about Vertosa at vertosa.com.
ABCann Medicinals Inc. is a wholly owned subsidiary of VIVO Cannabis™. VIVO Cannabis™ is recognized for trusted, premium cannabis products and services. It holds production and sales licences from Health Canada and operates world-class indoor and seasonal airhouse cultivation facilities with proprietary plant-growing technology in Hope, British Columbia and Napanee, Ontario. For more information visit: www.vivocannabis.com